The call for proposals for the 2024 Rx and Illicit Drug Summit has closed. The Rx and Illicit Drug Summit will be accepting abstracts for the 2025 agenda soon after the conclusion of the 2024 conference. Stay tuned for details. 

Abstracts are subject to acceptance by the Advisory Board. Only abstracts received by the submission deadline will be considered.

Abstracts will be accepted in the following categories: 

• ADVOCACY
• CLINICAL
• ILLICIT DRUGS
• PLENARY
• PREVENTION, OVERDOSE
• PREVENTION, PRIMARY
• PUBLIC SAFETY
• TECHNOLOGY
• TREATMENT & RECOVERY